Works matching DE "NOVAVAX Inc."


Results: 31
    1
    2
    3
    4
    5
    6

    Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35606-6
    By:
    • Logue, James;
    • Johnson, Robert M.;
    • Patel, Nita;
    • Zhou, Bin;
    • Maciejewski, Sonia;
    • Foreman, Bryant;
    • Zhou, Haixia;
    • Portnoff, Alyse D.;
    • Tian, Jing-Hui;
    • Rehman, Asma;
    • McGrath, Marisa E.;
    • Haupt, Robert E.;
    • Weston, Stuart M.;
    • Baracco, Lauren;
    • Hammond, Holly;
    • Guebre-Xabier, Mimi;
    • Dillen, Carly;
    • Madhangi, M.;
    • Greene, Ann M.;
    • Massare, Michael J.
    Publication type:
    Article
    7
    8

    COVID-19 vaccines in 2023.

    Published in:
    Australian Prescriber, 2023, v. 46, n. 3, p. 60, doi. 10.18773/austprescr.2023.020
    By:
    • Sharma, Ketaki;
    • Li-Kim-Moy, Jean
    Publication type:
    Article
    9
    10
    11

    Profiting from pandemics.

    Published in:
    Nature Biotechnology, 2009, v. 27, n. 6, p. 491, doi. 10.1038/nbt0609-491
    By:
    • Huggett, Brady
    Publication type:
    Article
    12

    Estradiol-Topical--Novavax.

    Published in:
    Drugs in R&D, 2003, v. 4, n. 1, p. 49, doi. 10.2165/00126839-200304010-00008
    Publication type:
    Article
    13

    News.

    Published in:
    Clinical Infectious Diseases, 2008, v. 46, n. 3, p. iii, doi. 10.1086/527439
    By:
    • Kaye, Donald
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Avian Flu Vaccine.

    Published in:
    JAMA: Journal of the American Medical Association, 2008, v. 299, n. 9, p. 1008, doi. 10.1001/jama.299.9.1008-c
    Publication type:
    Article
    24

    Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.

    Published in:
    Science Immunology, 2023, v. 8, n. 88, p. 1, doi. 10.1126/sciimmunol.adg7015
    By:
    • Routhu, Nanda Kishore;
    • Stampfer, Samuel David;
    • Lai, Lilin;
    • Akhtar, Akil;
    • Tong, Xin;
    • Yuan, Dansu;
    • Chicz, Taras M.;
    • McNamara, Ryan P.;
    • Jakkala, Kishor;
    • Davis-Gardner, Meredith E.;
    • St Pierre, E. Lovisa;
    • Smith, Brandon;
    • Green, Kristyn Moore;
    • Golden, Nadia;
    • Picou, Breanna;
    • Jean, Sherrie M.;
    • Wood, Jennifer;
    • Cohen, Joyce;
    • Moore, Ian N.;
    • Patel, Nita
    Publication type:
    Article
    25
    26

    Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices -United States, 2024–2025.

    Published in:
    MMWR: Morbidity & Mortality Weekly Report, 2024, v. 73, n. 37, p. 819, doi. 10.15585/mmwr.mm7337e2
    By:
    • Panagiotakopoulos, Lakshmi;
    • Moulia, Danielle L.;
    • Godfrey, Monica;
    • Link-Gelles, Ruth;
    • Roper, Lauren;
    • Havers, Fiona P.;
    • Taylor, Christopher A.;
    • Stokley, Shannon;
    • Talbot, H. Keipp;
    • Schechter, Robert;
    • Brooks, Oliver;
    • Daley, Matthew F.;
    • Fleming-Dutra, Katherine E.;
    • Wallace, Megan
    Publication type:
    Article
    27
    28
    29

    Rapid Manufacture and Release of a GMP Batch of Avian Influenza A(H7N9) Virus-Like Particle Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology.

    Published in:
    BioProcessing Journal, 2013, v. 12, n. 2, p. 4, doi. 10.12665/J122.Hahn
    By:
    • HAHN, TIMOTHY J.;
    • COURBRON, DENISE;
    • HAMER, MERVYN;
    • MASOUD, MALEK;
    • WONG, JAMES;
    • TAYLOR, KONNIE;
    • HATCH, JODY;
    • SOWERS, MIKE;
    • SHANE, ERICA;
    • NATHAN, MARGRET;
    • HUA JIANG;
    • ZIPING WEI;
    • HIGGINS, JOHN;
    • KWAN-HO ROH;
    • BURD, JOHN;
    • CHINCHILLA-OLSZAR, DIANA;
    • MALOU-WILLIAMS, MONIQUE;
    • BASKIND, DANIEL P.;
    • SMITH, GALE E.
    Publication type:
    Article
    30
    31